4 April 2017

Grant of options

Company, RNS

Grant of options

MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound training simulators for medical professionals, announces that Ian Whittaker, Chief Operating Officer, has today been granted 200,000 options over ordinary shares of the Company of 1 pence each (“Ordinary Shares”), pursuant to the MedaPhor Group plc EMI Share Option Scheme.

The exercise price of the options is 20.5p per Ordinary Share. 60,000 share options may be exercised between 5 April 2020 and 4 April 2027 (“the Lapse Date”), with the remaining options vesting subject to the achievement of certain financial performance criteria which must be achieved before the Lapse Date.

Full announcement can be viewed here.



MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Cenkos Securities Tel:  +44 (0)20 7397 8900
Bobbie Hilliam (Nominated Adviser)  
Julian Morse (Corporate Broking)  
Walbrook PR Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Paul McManus / Anna Dunphy Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001